With approximately half of the people living with diabetes not achieving glycemic targets, the need for better self-management is urgent. Real-time support powered by technology could be key to improving daily self-care and engagement.
LifeScan, a world leader in blood glucose monitoring and maker of the OneTouch® brand, and Welldoc present findings of a real-world observational study with one of the country’s leading health plans.* The study was designed to determine if people with type 2 diabetes would see improved health outcomes with the integration of the Welldoc technology into diabetes management activities.
Download the case study and learn more about:
- Study results, which demonstrated the vital role a virtual coach could play in improving diabetes self-management and engagement.
- How A1C lab values, all-cause ER visits, self-care, and costs were impacted.
- The power of LifeScan’s OneTouch Reveal® Plus app, powered by Welldoc's BlueStar®, when patients are more engaged in their own care.
* The study findings show people with type 2 diabetes who used LifeScan’s OneTouch Reveal® Plus app, powered by Welldoc’s BlueStar®, saw improved health outcomes with clinically significant reductions in A1C lab values and average blood glucose levels after three and six months.